News

Webull Corp (BULL) posts record Q2 results with 51% revenue growth, driven by PDT rule changes and AI adoption.

Alibaba Group Holding Ltd. is reclaiming its place as one of investors’ favorite Chinese technology stocks, on bets it can beat rivals in the combative artificial intelligence market.

JPMorgan Chase & Co. strategists warned that markets may view the US Treasury’s surprise effort to curb long-term borrowing costs as lacking credibility, potentially pushing up term premium and yields over time.

CHICAGO, Aug 19 () - Merck and Moderna's success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of tumors. Unlike chemotherapy, which kills both healthy and cancerous cells, or immunotherapy, which revs up the immune system, personalized cancer ‌vaccines train the immune system to specifically target mutations found only on a person's tumor.

The White House meeting put crypto regulation, prediction markets and Hyperliquid’s U.S. future in the spotlight.

Elimination of the Pattern Day Trader Rule aided trading volumes.

1. Moderna shares more than doubled after it reported successful results in an experimental mRNA-based cancer vaccine. The company and its partner Merck reported this morning that the vaccine succeeded in preventing cancer from coming back or spreading in a study of high-risk melanoma patients. The positive results sent Moderna’s share price soaring and rippled through drug industry stocks as investors saw the potential for more future blockbusters.

Nordson (NDSN) delivered earnings and revenue surprises of +5.18% and +4.96%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

AI cloud gross billings jump 82% to RMB1.33 billion, propelling total revenue to a record RMB3.07 billion and pushing adjusted operating margin to a historic 4.0%.

Despite Q2 revenue of just $6.7 million, Datavault AI Inc (DVLT) signs massive tokenization deals and expects significant Q4 revenue boost as exchanges go live.

US equity indexes rose on Wednesday after most Federal Open Market Committee participants agreed to

US equity indexes rose ahead of the close on Wednesday after the Treasury Department said it would i

Target Corp (TGT) delivers strong Q2 results with traffic up 3.6%, digital sales climbing 8.7%, and EPS more than doubling to $4.11, prompting an upward revision of its full-year outlook.

Walmart earnings are due early Thursday after a summer promotional pricing blitz to lure inflation-weary consumers. On Wednesday, WMT stock edged higher, near a key level. The big Dow Jones stock is the nation's and world's largest retailer by 2025 sales, according to the National Retail Federation.

The US Treasury Department’s decision to boost buybacks of long-dated bonds is complicating the outlook for issuance of short-term securities, including Treasury bills, which are expected to be used to finance the plan.

Falling yields revived speculative growth--but Tesla's operating margin remains the harder problem.

US equity indexes rose after midday Wednesday after the Treasury Department said it would increase b

Investors are rewarding resilient smaller-project demand despite a frozen housing market.

Investors rotated toward profitable drugmakers while personalized cancer-vaccine results energized biotechnology stocks.

The result could reshape Moderna's post-vaccine growth story

Estee Lauder (EL) shares rallied Wednesday after the cosmetics maker bumped up its fiscal 2027 opera

Wedbush sees another sign of memory inflation.

Bitcoin broke above $68,000 Wednesday, lifting shares of many crypto stocks as digital-currency leaders are scheduled to meet with President Trump in the White House this afternoon. The largest cryptocurrency gained about 6% and recently traded around $68,500, its largest percentage increase since March.

Industrial stocks have gotten expensive, but here are some with the most attractive growth prospects.

Bitcoin is surging, tokenized stocks are breaking records, and two retail brokerages are racing to claim the next era of American finance before regulators decide who gets left behind.

EL beats fiscal fourth-quarter estimates as sales rise 6%, fueled by Skin Care and Fragrance growth and sharply higher operating income.

Cogent Communications' 14% weekly rebound follows a narrower Q2 loss and margin gains, but revenue declines, Sprint runoff and debt risks keep the setup mixed.

Bitcoin broke out of a months long trading range, surging as much as 7.7%, amid optimism on the regulatory front with industry officials gathering at the White House.

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by regulators. Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors. In current studies, they are pairing it with Keytruda, a immunotherapy drug made by Merck.